Nam Phi cấp phép sử dụng khẩn cấp vắcxin của AstraZeneca

Ngày 27/1, Cơ quan dược phẩm Nam Phi thông báo nước này đã cấp phép sử dụng khẩn cấp vắcxin ngừa bệnh viêm đường hô hấp cấp COVID-19 của hãng AstraZeneca, đồng thời đang cân nhắc đơn đăng ký của các hãng dược phẩm khác, trong đó có Johnson & Johnson và Pfizer.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Mỹ khẳng định THAAD vẫn hiện diện tại Hàn Quốc, nhấn mạnh điều kiện chuyển giao quyền tác chiến

Mỹ khẳng định THAAD vẫn hiện diện tại Hàn Quốc, nhấn mạnh điều kiện chuyển giao quyền tác chiến

Thế giới
(Baothanhhoa.vn) - Trước các thông tin cho rằng hệ thống phòng thủ tên lửa tầm cao giai đoạn cuối (THAAD) từng triển khai tại Hàn Quốc đã được điều chuyển sang Trung Đông, Tư lệnh Lực lượng Mỹ tại Hàn Quốc khẳng định, hệ thống này vẫn đang được duy trì trên bán đảo Triều Tiên.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh